Advertisement
UK markets close in 6 hours 47 minutes

  • FTSE 100

    7,839.26
    -37.79 (-0.48%)
     

  • FTSE 250

    19,286.85
    -163.82 (-0.84%)
     

  • AIM

    741.10
    -4.19 (-0.56%)
     

  • GBP/EUR

    1.1684
    +0.0001 (+0.01%)
     

  • GBP/USD

    1.2440
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    51,947.64
    +2,519.26 (+5.10%)
     

  • CMC Crypto 200

    1,337.61
    +24.98 (+1.90%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CRUDE OIL

    82.85
    +0.12 (+0.15%)
     

  • GOLD FUTURES

    2,396.30
    -1.70 (-0.07%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,698.15
    -139.25 (-0.78%)
     

  • CAC 40

    7,978.51
    -44.75 (-0.56%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

Smith & Nephew CEO Bohuon diagnosed with cancer

Reuters - UK Focus

LONDON, Feb 1 (Reuters) - Smith & Nephew Plc (LSE: SN.L - news) , Europe's biggest maker of artificial hips and knees, said on Monday that its Chief Executive Olivier Bohuon has been diagnosed with a highly treatable form of cancer.

The company said in a statement that Bohuon would remain in his role during his treatment period, which will begin later this month.

It (Other OTC: ITGL - news) said Bohuon will be actively involved in running the company while undergoing chemotherapy, which is expected to be completed by late autumn.

"The board has approved provisional governance procedures to ensure the effective operation of Smith & Nephew during the treatment period, including Chairman Roberto Quarta providing executive oversight if required," it said. (Reporting by Li-mei Hoang; editing by Kate Holton)